JCB logo
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.200805063
The Journal of Cell Biology, Vol. 184, No. 6, 923-933
The Rockefeller University Press, 0021-9525 $30.00
© Catalucci et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2088K)
Right arrow PDF+supp data (3456K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catalucci, D.
Right arrow Articles by Condorelli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catalucci, D.
Right arrow Articles by Condorelli, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Akt regulates L-type Ca2+ channel activity by modulating Cav{alpha}1 protein stability



Daniele Catalucci1,3, Deng-Hong Zhang1, Jaime DeSantiago4,5, Franck Aimond6, Guillaume Barbara7, Jean Chemin7, Désiré Bonci8, Eckard Picht4,5, Francesca Rusconi3, Nancy D. Dalton1, Kirk L. Peterson1, Sylvain Richard6, Donald M. Bers4,5, Joan Heller Brown2, and Gianluigi Condorelli1,3

1 Division of Cardiology, Department of Medicine and 2 Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093
3 Istituto di Ricovero e Cura a Carattere Scientifico Multimedica, Milan 20138, Italy
4 Department of Pharmacology, School of Medicine and 5 Genome and Biomedical Sciences Facility, University of California, Davis, Davis, CA 95616
6 Physiopathologie Cardiovasculaire, Institut National de la Santé et de la Recherche Médicale Unité 637, Université Montpellier 1, Montpellier 34295, France
7 Département de Physiologie, Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5203, Institut National de la Santé et de la Recherche Médicale Unité 661, Université Montpellier 2, Montpellier 34295, France
8 Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Istituto Superiore Sanità, Rome 00161, Italy

Correspondence to Daniele Catalucci: daniele.catalucci{at}itb.cnr.it; or Gianluigi Condorelli: gcondorelli{at}ucsd.edu

The insulin IGF-1–PI3K–Akt signaling pathway has been suggested to improve cardiac inotropism and increase Ca2+ handling through the effects of the protein kinase Akt. However, the underlying molecular mechanisms remain largely unknown. In this study, we provide evidence for an unanticipated regulatory function of Akt controlling L-type Ca2+ channel (LTCC) protein density. The pore-forming channel subunit Cav{alpha}1 contains highly conserved PEST sequences (signals for rapid protein degradation), and in-frame deletion of these PEST sequences results in increased Cav{alpha}1 protein levels. Our findings show that Akt-dependent phosphorylation of Cavβ2, the LTCC chaperone for Cav{alpha}1, antagonizes Cav{alpha}1 protein degradation by preventing Cav{alpha}1 PEST sequence recognition, leading to increased LTCC density and the consequent modulation of Ca2+ channel function. This novel mechanism by which Akt modulates LTCC stability could profoundly influence cardiac myocyte Ca2+ entry, Ca2+ handling, and contractility.


D. Catalucci and D.-H. Zhang contributed equally to this paper.

Abbreviations used in this paper: AID, {alpha}1-interacting domain; ANOVA, analysis of variance; DN, dominant-negative; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KO, knockout; LTCC, L-type Ca2+ channel; PLN, phospholamban; Ryr, ryanodine receptor; siAkt, small interfering Akt; SR, sarcoplasmic reticulum; TEA, tetraethylammonium; Tg, transgenic; WT, wild type.

© 2009 Catalucci et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents